Effect and cost of perioperative use of antibiotics in coronary artery bypass grafting: a randomized controlled study
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.0366-6999.2011.05.012
- Key Word:
- coronary artery bypass grafting;perioperative period;antibiotics;cost;intervention
Abstract： Background Bacterial infections remain a serious complication following coronary artery bypass grafting (CABG). The objective of the study was to determine the effectiveness of a guideline for the appropriate use of antibiotics in CABG during the perioperative period.Methods Six hundred and fourteen hospitalized patients who had undergone CABG from January to June 2006 were randomly allocated to an intervention group and a control group. The data on the hospital stay, days of antibiotic used,types of prophylactic antibiotics used, surgical wound infection and pulmonary infection and antibiotic costs for the patients were compared.Results The postoperative hospitalization days of the intervention group were significantly fewer than that for the control group (P＜0.05). The time of antibiotic use and post-infection treatment time were also significantly less in the intervention group than in the control group (P ＜0.05). The average hospital daily cost and total cost of antibiotics were less in the intervention group than in the control group (P＜0.05). Compared with the control group, prophylactic antibiotic use in the intervention group was more reasonable.Conclusions The guideline for the appropriate use of antibiotics in CABG during the perioperative period is effective strategies for reducing antibiotic costs, the time of antibiotic use and post-infection treatment time without compromising the patients' clinical outcome.
- [1]李家斌,马亦林,王中新,等.肺炎克雷伯菌的流行状况及产生耐药性的危险因素分析[J].2002,(8).
- [2]Parry G W,Holden S R,Shabbo F P.Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice.[J].1993.
- [3]L, Bogg,H, Dong,K, Wang,etc.The cost of coverage: rural health insurance in China.[J].1996,11(3).
- [4]S C, Beyea.Preventing surgical site infections--guiding practice with evidence.[J].2000,72(2).
- [5]Covington JF,Lancaster AD,Thomas CS,etc.The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients.[J].2001,22(10).
- [6]Reynolds L,McKee M.Factors influencing antibiotic prescribing in China: an exploratory analysis.[J].2009,90(1).
- [7]H, Dong,L, Bogg,K, Wang,etc.A description of outpatient drug use in rural China: evidence of differences due to insurance coverage.[J].1900,14(1).
- [8]Vrettos lerodiakonou,Vangelis G. Alexiou,George Peppas,etc.Antimicrobial Prophylaxis in Surgery: An International Survey[J].2010,11(4).
- [9]Hengjin Dong,Lennart Bogg,Clas Rehnberg,etc.Association between health insurance and antibiotics prescribing in four counties in rural China[J].1999,48(1).
- [10]Elamin H, Elbasha.Deadweight loss of bacterial resistance due to overtreatment.[J].2003,12(2).
- [11]Ramanan, Laxminarayan,David L, Smith,Leslie A, Real,etc.On the importance of incentives in hospital infection control spending.[J].2005,5(27).
- [12]Sipahi OR.Economics of antibiotic resistance.[J].2008,6(4).
- [13]Bruce R. Levin,Sebastian Bonhoeffer,Marc Lipsitch.Evaluating treatment protocols to prevent antibiotic resistance[J].1997,94(22).
- [14]Pediaditis J,Metalidis S,Kioumis J,etc.Prevalence of nosocomial infections after surgery in Greek hospitals: results of two nationwide surveys.[J].2004,25(4).
- [15]S D, Holmberg,S L, Solomon,P A, Blake.Health and economic impacts of antimicrobial resistance.[J].1900,9(6).